BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM; Perihilar Cholangiocarcinoma Collaboration Group. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Ann Surg Oncol 2020;27:2311-8. [PMID: 32103419 DOI: 10.1245/s10434-020-08258-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Vaghiri S, Alaghmand Nejad S, Kasprowski L, Prassas D, Safi SA, Schimmöller L, Krieg A, Rehders A, Lehwald-Tywuschik N, Knoefel WT. A single center comparative retrospective study of in situ split plus portal vein ligation versus conventional two-stage hepatectomy for cholangiocellular carcinoma. Acta Chir Belg 2022;:1-12. [PMID: 35317718 DOI: 10.1080/00015458.2022.2056680] [Reference Citation Analysis]
2 Yang X, Lan T, Zhong H, Zhang Z, Xie H, Li Y, Huang W. To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer. J Healthc Eng 2022;2022:8223336. [PMID: 35356619 DOI: 10.1155/2022/8223336] [Reference Citation Analysis]
3 Benzing C, Haiden LM, Krenzien F, Mieg A, Wolfsberger A, Atik CF, Nevermann N, Fehrenbach U, Schöning W, Schmelzle M, Pratschke J. Textbook outcome after major hepatectomy for perihilar cholangiocarcinoma - definitions and influencing factors. Langenbecks Arch Surg 2022. [PMID: 35246771 DOI: 10.1007/s00423-022-02467-y] [Reference Citation Analysis]
4 Tzedakis S, Sindayigaya R, Dhote A, Marchese U, Barret M, Belle A, Coriat R, Barat M, Soyer P, Fuks D. Perihilar cholangiocarcinoma: What the radiologist needs to know. Diagnostic and Interventional Imaging 2022. [DOI: 10.1016/j.diii.2022.03.001] [Reference Citation Analysis]
5 Benzing C, Schmelzle M, Atik CF, Krenzien F, Mieg A, Haiden LM, Wolfsberger A, Schöning W, Fehrenbach U, Pratschke J. Factors associated with failure to rescue after major hepatectomy for perihilar cholangiocarcinoma: A 15-year single-center experience. Surgery 2022. [DOI: 10.1016/j.surg.2021.08.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 van Keulen AM, Olthof PB, Cescon M, Guglielmi A, Jarnagin WR, Nadalin S, Pratschke J, Ratti F, Troisi RI, Groot Koerkamp B, Buettner S, Erdmann JI, On Behalf Of The 'Perihilar Cholangiocarcinoma Collaboration Group'. Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure? Cancers (Basel) 2021;13:6260. [PMID: 34944880 DOI: 10.3390/cancers13246260] [Reference Citation Analysis]
7 Lang H, van Gulik TM. Extended Right-hemihepatectomy Is Preferred for Perihilar Cholangiocarcinoma. Ann Surg 2021;274:33-4. [PMID: 33605597 DOI: 10.1097/SLA.0000000000004821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Benzing C, Krenzien F, Mieg A, Wolfsberger A, Andreou A, Nevermann N, Pelzer U, Fehrenbach U, Haiden LM, Öllinger R, Schöning W, Schmelzle M, Pratschke J. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbecks Arch Surg 2021;406:1499-509. [PMID: 34075473 DOI: 10.1007/s00423-021-02154-4] [Reference Citation Analysis]
9 Ruzzenente A, Bagante F, Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Koerkamp BG, Jarnagin WR, Nadalin S, Pratschke J, Schmelzle M, Sparrelid E, Lang H, Iacono C, van Gulik TM, Guglielmi A; Perihilar Cholangiocarcinoma Collaboration Group. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group. Ann Surg Oncol 2021. [PMID: 33956275 DOI: 10.1245/s10434-021-09905-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Elfrink AKE, Olthof PB, Swijnenburg RJ, den Dulk M, de Boer MT, Mieog JSD, Hagendoorn J, Kazemier G, van den Boezem PB, Rijken AM, Liem MSL, Leclercq WKG, Kuhlmann KFD, Marsman HA, Ijzermans JNM, van Duijvendijk P, Erdmann JI, Kok NFM, Grünhagen DJ, Klaase JM, Te Riele WW, Buis CI, Patijn GA, Braat AE, Dejong CHC, Hoogwater FJH, Molenaar IQ, Besselink MGH, Verhoef C; Dutch Hepato Biliary Audit Group, Collaborators., Collaborators. Factors associated with failure to rescue after liver resection and impact on hospital variation: a nationwide population-based study. HPB (Oxford) 2021:S1365-182X(21)00120-9. [PMID: 34090804 DOI: 10.1016/j.hpb.2021.04.020] [Reference Citation Analysis]
11 Jansson H, Olthof PB, Bergquist A, Ligthart MAP, Nadalin S, Troisi RI, Groot Koerkamp B, Alikhanov R, Lang H, Guglielmi A, Cescon M, Jarnagin WR, Aldrighetti L, van Gulik TM, Sparrelid E; Perihilar Cholangiocarcinoma Collaboration Group. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study. HPB (Oxford) 2021:S1365-182X(21)00111-8. [PMID: 33975797 DOI: 10.1016/j.hpb.2021.04.011] [Reference Citation Analysis]
12 Franken LC, Olthof PB, Erdmann JI, van Delden OM, Verheij J, Besselink MG, Busch OR, van Gulik TM. Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter? Hepatobiliary Surg Nutr 2021;10:154-62. [PMID: 33898556 DOI: 10.21037/hbsn-19-948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 van Keulen AM, Franssen S, van der Geest LG, de Boer MT, Coenraad M, van Driel LMJW, Erdmann JI, Haj Mohammad N, Heij L, Klümpen HJ, Tjwa E, Valkenburg-van Iersel L, Verheij J, Groot Koerkamp B, Olthof PB; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Nationwide treatment and outcomes of perihilar cholangiocarcinoma. Liver Int 2021;41:1945-53. [PMID: 33641214 DOI: 10.1111/liv.14856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Kawasaki H, Akazawa Y, Razumilava N. Progress toward improving outcomes in patients with cholangiocarcinoma. Curr Treat Options Gastroenterol 2021;19:153-68. [PMID: 33883870 DOI: 10.1007/s11938-021-00333-2] [Reference Citation Analysis]
15 Gringeri E, Gambato M, Sapisochin G, Ivanics T, Lynch EN, Mescoli C, Burra P, Cillo U, Russo FP. Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology. J Clin Med 2020;9:E1353. [PMID: 32380750 DOI: 10.3390/jcm9051353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Olthof PB, van Gulik TM. ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization. Ann Surg Oncol 2020;27:2319-20. [PMID: 32152772 DOI: 10.1245/s10434-020-08333-9] [Reference Citation Analysis]